Disclosure Of Cash Flow Statement [Text Block]

Biofrontera AG - Filing #6464128

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2023-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Zahlungsmittel und Zahlungsmitteläquivalente
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
3,124 EUR
3,080 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.